One of the prominent features of A-T is progressive neurodegeneration. We have previously reported that primary astrocytes isolated from Atm -/-mice grow slowly and die earlier than control cells in culture. However, the mechanisms for this remain unclear. We show here that intrinsic elevated intracellular levels of reactive oxygen species (ROS) are associated with the senescence-like growth defect of Atm -/-astrocytes. This condition is accompanied by constitutively higher levels of extracellular signal regulated kinase (ERK) 1/2 phosphorylation and p16
Ink4a
in Atm -/-
astrocytes. We also observe that ROS-induced upregulation of p16
Ink4a occurs correlatively with ERK1/2-dependent downregulation and subsequent dissociation from chromatin of Bmi-1. Furthermore, both mitogen-activated protein kinase (MEK) inhibitor PD98059 and antioxidant N-acetyl-L-cysteine (NAC) restored normal proliferation of Atm -/-astrocytes. These results suggest that ATM is required for normal astrocyte growth through its ability to stabilize intracellular redox status, and that inability to control ROS is the molecular basis of limited cell growth of Atm -/-astrocytes. This defect may be mediated by a mechanism involving ERK1/2 activation and Bmi-1 derepression of p16
Ink4a . These data identify new potential targets for therapeutic intervention in A-T neurodegeneration.
A prominent feature of ataxia-telangiectasia (A-T) is neurodegeneration that is caused by mutations in the Atm (ataxia telangiectasia mutated) gene (1) (2) (3) . The Atm gene product, ATM protein kinase, regulates the cell cycle in response to DNA damage and to oxidative stress (4) (5) . Within the central nervous system (CNS), proper responses to ROS are required to prevent neurodegeneration (6) (7) (8) (9) . Others have shown that exogenous antioxidants prevent Purkinje cell death (10) and correct neurobehavioral deficits in Atm -/-mice (11) (12) . These findings suggest that abnormalities in redox status contribute to the A-T phenotype (13) (14) (15) (16) . Although increased oxidative stress has been shown to characterize ATM deficiency in the CNS, the mechanisms by which oxidative stress promotes neuronal cell loss in A-T remain unclear.
A-T neurodegeneration is primarily due to loss of cerebella Purkinje neurons and to malfunction of other neuronal cells as well (3) . Neurons in the CNS depend upon astrocytes for structural, functional and thiol support (17) (18) . For example, Purkinje neurons in the cerebellum rely heavily on their supporting Bergmann astrocytes (19) . We have shown that Bergmann astrocytes of Atm -/-mice are under oxidative stress (20) , implying that oxidative stress resulting from loss of ATM may promote astrocyte dysfunction. Others have also shown that cultured astrocytes from Atm -/-mice have cell cycle and growth defects (21) , and that astrocytes isolated from Atm -/-mouse embryos grow poorly in culture and readily undergo senescence (15, 20) . These observations imply that ATM is essential for normal astrocyte growth and maturation. In light of the importance of astrocytes in supporting neurons against oxidative stress, we hypothesize that aberrant growth and function of Atm -/-astrocytes may contribute to neuron loss in A-T.
We show here that Atm -/-astrocytes exhibit senescence-like growth arrest, compared with to the growth characteristics of their wild-type (Atm +/+ ) counterparts. We also show that elevated ROS levels are one of the causes of proliferation defects in Atm -/-astrocytes. This conclusion is based on the observation that defective cell growth of Atm -/-astrocytes is restored to normal by the Ink4a . Bmi-1, a polycomb group RING finger protein 4 has been implicated in proliferation of several cell types, through its transcriptional repression of p16
Ink4a (22) (23) . We observe that ROS-induced Bmi-1 downregulation and dissociation from chromatin are both ERK1/2 dependent. This suggests that the upregulation of p16
Ink4a is mediated by a mechanism involving ERK1/2 activation and Bmi-1's loss-of-function as transcription repressor of p16
Ink4a . Finally, we show that the MEK inhibitor PD98059 reverse p16
Ink4a upregulation and chromatin dissociation of Bmi-1. Furthermore, knockdown of p16
Ink4a
greatly corrected the cell growth defect in Atm -/-astrocytes.These studies identify a role of ATM in controlling normal astrocyte growth and maturation. This is carried out by suppression of oxidative stress-dependent signaling pathways.
EXPERIMENTAL PROCEDURES

Mice Atm
-/-mice were originally generated by C. Barlow (24) . For this study, they were purchased from the Jackson Laboratories (Bar Harbor, ME Cells and cell culture Immortalized murine C1 astrocytes were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and antibiotics (100 units/ml penicillin and 100 μg/ml streptomycin) (25) . Cells were passaged biweekly and used for experiments while in the exponential growth phase. Primary astrocytes were isolated from 1 to 2-day-old newborn mouse pups by a method described previously (20, 26) . Whole brain of each newborn mouse was removed and minced separately in ice-cold DMEM/F12 medium. A single-cell suspension was obtained by passing the minced tissue through a 70-m nylon mesh cell strainer. The cells were plated onto poly-L-lysinecoated 10-mm flasks and grown in DMEM/F12 medium, supplemented with 10% FBS, 5 units/ml penicillin, 5 g/ml streptomycin and 2.5 g/ml Fungizone. The cells were cultured for 4 days in an incubator with 5% CO 2 atmosphere at 37°C until reaching confluence. They were passaged by trypsinization. Cells from passages 4 or 5 were used for all experiments. Astrocytes consistently by the fourth or fifth passage were > 99% GFAP positive (27) .
Chemical reagents ATM inhibitor KU55933 (10 μM) was purchased from Sigma. MEK inhibitor PD98059 (50 μM) was purchased from BD Biosciences, and antioxidant NAC (4 mM) was kindly provided by M. Yan (M. D. Anderson Cancer Center) (28) .
Analysis of cell senescence SA -gal assay kit (Cell Signaling) was used to visualize senescent cells. Astrocytes were cultured in 6-well plates for 2 days, and then fixed after washing twice with PBS. The cells were further incubated for 24 hours in the presence of staining solution-containing Xgal. Senescent cells were distinguished from viable cells using -galactosidase, which is blue under the microscope. Ink4a and anti-actin (Santa Cruz Biotechnology).
Analysis of intracellular ROS
SiRNA-mediated knockdown For siRNA knockdown of Atm, cells were transfected for 48 hours with 20 nM siRNA (mouse-specific Atm) in medium containing 10% (v/v) FBS using Lipofectamine reagent (Invitrogen) according to the manufacturer's protocol for cells. Validated siRNA (SMARTpool) was obtained from Dharmacon. The negative control siRNA used was siCONTROL, which contains at least 4 mismatches to all known human, mouse, and rat genes. For mock transfection, we used siRNA suspension buffer and Lipofectamine containing no siRNA. For siRNA knockdown of p16
Ink4a , mouse-specific p16
Ink4a siRNA was purchased from Santa Cruz Biotechnology.
Immunofluorescence The cells were fixed with 4% paraformaldehyde in PBS for 30 minutes at room temperature, and then permeabilized with 0.1% Triton X-100 in PBS for 15 minutes. For staining with antibodies, cells were incubated for 2 hours at 37°C with 10% FBS in PBS. Primary antibodies were added, and the cells were incubated at 4°C overnight. The cells were then washed three times in PBS/0.1% Triton X-100 for 5 minutes each, and fluorescent secondary antibodies were added for 1 hour at 37°C. The nuclei were stained with 4 , 6-diamidino-2-phenylindole, and slides were mounted in Slowfade (Molecular Probes). Cells were imaged under an Olympus IX2-SL microscope equipped with a 400 objective and an Olympus DP 70 digital camera connected to a PC computer.
Statistics For each experiment, data are presented as the mean ± S.D. of values. Each experiment was repeated at least three times. Statistical comparisons of values for Atm +/+ vs. Atm -/-mice, and for untreated control vs. treated samples were made using the Mann-Whitney U test. Differences were considered significant when p < 0.05.
RESULTS
Loss of ATM impairs proliferation in astrocytes
We have reported previously that ATM-deficient primary astrocytes grow slowly, become senescent, and die in culture (20) . These results are consistent with those reported by Gosink et al (21 (Fig. 1B, left panel) . This is consistent with our findings for C1 astrocytes, a murine immortalized astrocyte cell line (25) . While the ATM inhibitor, KU55933 slightly decreases astrocytes proliferation, loss of ATM by ATM small interfering RNA (ATM siRNA) reduced cell proliferation by ~40% (Fig. 1B , right panel). To obtain direct evidence that ATM deficiency causes cell senescence, a specific senescence-associated -galactosidase (SAgal) assay was performed after 2-days of culture. astrocytes to normal levels ( Fig. 2A) . This result suggests that elevated ROS levels are intrinsic characteristics of cells lacking ATM. This is consistent with our results from C1 astrocytes treated with ATM specific inhibitor, KU55933, which show higher levels of intracellular ROS compared to untreated control cells (data not shown). For direct evidence that defective proliferation of Atm -/-astrocytes is due to elevated ROS levels, we treated Atm -/-astrocytes with NAC and compared their proliferation rates to those of untreated cells. Figure 2B shows that proliferation rates for Atm -/-astrocytes were increased by treatment with NAC, showing nearly 2-2.5 times higher rates than untreated Atm -/-counterpart at 3 and 4 days after subculturing. This effect of NAC was confirmed by photomicrograph, which disclosed increased cell density by NAC (Fig. 2C) . This is consistent with our findings that NAC decreases the proportion of senescent cells in Atm -/-astrocyte cultures (Fig. 2D) (Fig. 3C ). These results indicate that H 2 O 2 inhibits astrocytes proliferation through elevating intracellular ROS, regardless of their ATM status.
We then investigated the effects of ROS on several known key intermediates associated with cell proliferation. The inhibitors of cyclindependent kinases (CDK) are considered to play an important role in cell cycle arrest and premature senescence (30 (Fig. 4A) , which is consistent with the fact that Bmi-1 promotes cell proliferation via repression of CDK inhibitors. In figure 3D, (32, 33 ). Therefore, we tested the effect of ROS on ERK1/2 downstream mediators. Upon phosphorylation at two amino acids (Thr202/Tyr204), ERK1/2 translocates into the nucleus, where it phosphorylates its substrates.
Since p16
Ink4a expression level does not depend on phosphorylation by ERK1/2, it is not a direct substrate of activated ERK1/2. Instead, p16
Ink4a expression is negatively regulated by Bmi-1 (34) . Amino acid sequence analysis indicates that Bmi-1 has two predicted consensus motifs for ERK1 phosphorylation (http://www.scansite. mit.edu). We thus asked whether ROS-induced ERK1/2 signaling has effects on Bmi-1 function as a transcription repressor for p16
Ink4a . The polycomb group (PcG) proteins including Bmi-1 function as transcription repressors. Chromatin association of these proteins can be demonstrated by puncta in the nucleus in previous study (35 Figure 5C shows that H 2 O 2 -induced Bmi-1/chromatin dissociation is significantly inhibited by PD98059. This suggests that Bmi-1 dissociation from chromatin occurs via ERK1/2 signaling. In addition, H 2 O 2 inhibits astrocyte proliferation, but PD98059 partially rescues it (Fig.  5D ). Taken together with increased proliferation by PD98059, reversion of chromatin dissociation and restoration of Bmi-1 by PD98059 indicate that H 2 O 2 -induced proliferation decrease is associated to Bmi-1 dysfunction by ERK1/2 signaling.
Next, we assessed the effect of ATM deficiency on endogenous Bmi-1 localization using Atm -/-astrocytes. Figure 5F shows that Bmi-1 is downregulated, and less Bmi-1 associate with chromatin in Atm -/-astrocytes than does in Atm
astrocytes. These results are consistent with previous findings of Bmi-1 downregulation and p16 Ink4a upregulation that occur in Atm -/-astrocytes (Fig. 4A) . The data link p16
Ink4a upregulation to Bmi-1 downregulation in Atm -/-astrocytes, in turn also link these two events to elevated intracellular ROS levels. Since PD98059 also restored normal Bmi-1 and p16
Ink4a levels in Atm -/-astrocytes, we conclude that ERK1/2 mediates Bmi-1 downregulation and chromatin dissociation, as well as p16
Ink4a upregulation.
Restoration of normal proliferation of Atm / astrocytes by inactivation of ERK1/2 signaling or knockdown of p16 Ink4a
We next asked whether activation of ERK1/2 impaires survival and proliferation of Atm -/-astrocytes, and whether inhibiting ERK1/2 signaling restores defective cell growth. We established cultures of Atm -/-astrocytes in the presence of PD98059. Growth curve analysis for 5 days showed that PD98059 partially rescued Atm -/-astrocytes from defective proliferation (Fig. 6A) . The restorative actions of PD98059 were also evident in culture, as shown by increase in cell density (Fig. 6B) . However, the positive effect of PD98059 on proliferation of Atm -/-astrocytes was not comparable to that of the antioxidant NAC. In addition, PD98059 appeared to inhibit mitogenic pathways in Atm +/+ astrocytes, since it reduced growth rate and proliferation in these cells. In normal Atm +/+ mice, most astrocytes are quiescent, and thus ERK1/2 signaling is suspended in an inactive state. However, Atm -/-astrocytes maintain constitutive ERK1/2 signaling, associated with oxidative stress-condition.
In spite of its inhibitory effect on Atm +/+ astrocytes proliferation, PD98059 partially restored Bmi-1 levels in Atm -/-astrocytes. In addition, both NAC and PD98059 reduced levels of p21 cip1 and p16 Ink4a in Atm -/-astrocytes to levels similar to those in Atm +/+ astrocytes. In accordance of these results, level of phospho-Rb was also increased by NAC and PD98059 (Fig. 6C) . These results provide direct evidence linking defective growth of Atm -/-astrocytes to activation of ERK1/2 signaling as a result of oxidative stress. However, PD98059 has modest and partial rescuing effect on Atm -/-astrocytes proliferation, indicating that there may be additional pathways associated with defective proliferation in Atm -/-astrocytes.
Since increases in cell senescence and p16
Ink4a
level were observed in Atm -/-astrocytes, we next decided to access whether p16
Ink4a upregulation is responsible for inducing cell senescence, and whether inhibition of p16
Ink4a expression would reverse the defective growth phenotype of Atm -/-astrocytes. Ink4a was knockdowned in both Atm +/+ and Atm -/-astrocytes using siRNA against mouse p16
Ink4a . Figure 6D shows that more senescent cells were observed in Atm -/-astrocytes than in Atm +/+ astrocytes. However, Atm -/-astrocytes when p16
Ink4a was knockdowned had fewer senescent cells than did these cells whose p16 Ink4a was intact.
DISCUSSION
In A-T patients, Purkinje neuron loss in the cerebellum is the most critical feature of the neuropathological phenotype (37) . Up to now, therefore, most studies have focused on the effects of ATM deficiency in neurons, with the role(s) of astrocytes going unexplored. However, accumulating evidence now suggests that astrocytes are key elements serving pivotal functions in the central nervous system, including structural and redox support for neuron, neurotransmitter synthesis, and transport of nutrients and metabolic precursors to neurons (17, 19, (38) (39) (40) . Previous studies have reported that transgenic and knockout mouse models for certain astrocyte-specific proteins result in neurodegenerative disorders (41) (42) . This implies that abnormalities in astrocytes might also cause neuropathophysiology of A-T. This is consistent with earlier observations by others that Purkinje cell survival in Atm-deficient mice is partially reversed when these cells are cultured in the presence of Atm +/+ astrocyte-conditioned medium (18) . It will be important now to determine whether Atm -/-astrocytes have cytotoxic effects for neurons in co-culture. Studies now in progress in our lab will address effects of Atm -/-astrocytes on neurons in this context.
At normal concentrations, ROS play a role in cellular functions involving signal transduction (43) (44) . However, an imbalance between generation of ROS and capacity of antioxidants to neutralize ROS can result in disruption of cellular redox status, leading to oxidative stress (45) (46) (47) . Mammalian cells have therefore evolved a wide range of mechanisms, including ATM, for maintaining normal levels of intracellular ROS. Neuronal cells require large quantities of oxygen to function because of their high metabolic rate. As a result, neurons generate high levels of ROS. For this reason, the CNS is very vulnerable to ROS imbalance and accumulation. In general, low doses of H 2 O 2 promote cell proliferation, whereas high levels of ROS elicit cell cycle arrest, senescence, and apoptosis (48) . Our data show that Atm -/-astrocytes have a lower proliferation rate than that of normal cells. We previously observed increased spontaneous DNA synthesis in cultured Atm -/-astrocytes relative to Atm +/+ astrocyte in spite of their decreased proliferation (20) . The reason for this discrepancy is unknown. However, it is possible that abnormally elevated DNA synthesis in Atm -/-astrocytes may occur without cell division. This is in turn could elevate ROS production in the cells (15) .
Our observation that p21 Cip1 is upregulated in Atm -/-astrocytes ( Fig. 4B ) and that PD98059 inhibits p21
Cip1 upregulation (data not shown) are consistent with those from a previous study (26) . The Ink4a/Arf locus encodes two proteins, p16 and Arf are important components in Rb and p53 pathways, respectively, and both proteins function in cell cycle regulation (52) (53) . Bmi-1 is a potent repressor of both Ink4a and Arf. Our data suggest that Bmi-1 downregulation and dissociation from chromatin with resultant p16
Ink4a upregulation may contribute to the defective proliferation and premature senescence of Atm -/-astrocytes. A very interesting observation made by other researchers is that Bmi-1 knockout mice progressively develop A-T-like motor abnormalities, such as ataxia (22) . This information substantiates the observations reported above, and supports the idea that CNS pathology is similar if either ATM or Bmi-1 is absent. Since derepression of the Ink4a/Arf gene locus has been correlated with Bmi-1-deficient phenotypes in the nervous system, it is important to determine whether the deletion of both Ink4a and Arf genes restores functions of Atm -/-astrocytes. Notably, we observed that knockdown of Ink4a restores proliferation of Atm -/-astrocytes (Fig. 6D) . Furthermore, work by others has also shown that the A-T like motor abnormalities observed in Bmi-1 knockout mice restored in Bmi-
Ink4a-/-double knockout mice (54) . This result further substantiates that p16
Ink4a plays a role in Bmi-1 deficient condition.
We have shown that Bmi-1/chromatin association is disrupted by H 2 O 2 (Fig. 5A, B, &C) . Previous studies on Bmi-1 have reported that its function as transcription repressor is regulated by its phosphorylation status (35) . Since Bmi-1 contains two predicted ERK1 phosphorylation sites, we asked whether Bmi-1 phosphorylation is induced by oxidative stress, and whether it is ERK1/2 dependent. We reasoned that ROSinduced phosphorylation of Bmi-1 may directly or indirectly contribute to its chromatin dissociation, which in turn would result in de-repression of p16
Ink4a . Since no specific antibody is available to detect phosphorylated form of Bmi-1, its phosphorylation was determined by mobility shift on gels in the presence of phosphatase inhibitors. These experiments demonstrated that H 2 O 2 treatment causes the mobility shift of Bmi-1 (data not shown). However, even though downregulation and chromatin dissociation of Bmi-1 occur in Atm -/-astrocytes, no intrinsic difference in Bmi-1 phosphorylation is observed between Atm +/+ and Atm -/-astrocytes in westernblotting analysis (Fig. 4A ). This might be explained by the fact that the mobility shift of Bmi-1 is able to be detected for only short time after H 2 O 2 treatment, after which time Bmi-1 levels decreased (Fig. 4D ). Therefore, it is possible that phosphorylation of Bmi-1 may lead to its degradation. It will be interesting to determine whether inhibition of proteasomal degradation restores functions of Atm -/-astrocytes by preventing Bmi-1 degradation.
In recent years, accumulating evidence has indicated that protein kinase activities are redoxsensitive because key cysteine residues in these proteins can undergo posttranslational modifications by oxidants. H 2 O 2 -induced formation of disulfide bonds in protein kinases has been documented, suggesting that kinases function as redox sensors and that H 2 O 2 -induced conformational changes or formation of dimers from disulfide bonds triggers kinase activation (45, 55) . This is consistent with our observation that ATM is activated in response to H 2 O 2 (data not shown). Although at present the mechanism of how H 2 O 2 -induced ERK1/2 activation is unclear, we speculate that a candidate upstream mediator, such as receptor tyrosine kinase (RTK) may be responsible for H 2 O 2 -induced ERK1/2 activation, since others have shown that upstream RTK may act as a trigger for such events (56) . Our further studies will address the role of RTK in modulating H 2 O 2 -induced ERK1/2 signaling.
In conclusion, our data demonstrate that ATM is required to maintain normal growth of astrocytes by controlling intracellular levels of ROS. The absence of ATM limits the growth of astrocytes through ERK1/2-dependent mechanisms, including downregulation and chromatin dissociation of Bmi-1, and subsequent upregulation of p16
Ink4a . The events are prevented by antioxidants and inhibited by inactivation of MEK, which is upstream of ERK1/2 (Fig.7) . These data therefore identify a novel mechanism by which ATM deficiency leads to the astrocytes growth arrest, and they identify new targets for effective pharmacological intervention in A-T patients. Fig. 7 . Proposed model of a role for ATM in the maintenance of normal astrocyte proliferation ATM is necessary to control intracellular levels of ROS. In the absence of ATM, elevated levels of ROS elicit oxidative stress and limited growth of astrocytes, through multiple ERK1/2-dependent mechanisms, including downregulation and chromatin dissociation of Bmi-1, as well as upregulation of p16 Ink4a . Abnormal proliferation of Atm / astrocytes may lead to oxidative stress in entire central nervous system, and eventually to neurodegeneration. Oxidative stress mediated-growth defects of Atm / astrocytes may be prevented by antioxidants, and normal astrocyte proliferation partially restored by inhibition of ERK1/2 signaling. Arrows denote increase or decrease when ATM is absent.
